Summary

GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico — Insufficienza cardiaca) provides support for the use of fish oil supplements in patients with symptomatic heart failure but indicates no benefit of statin therapy in this patient population. Fish oil supplements reduced the risk of all-cause death or hospitalization for cardiovascular causes, while treatment with rosuvastatin had no effect on these outcomes.